INR 95.68
(1.57%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.01 Billion INR | 14.34% |
2022 | 888.67 Million INR | 12.93% |
2021 | 786.9 Million INR | 3.02% |
2020 | 763.84 Million INR | 27.06% |
2019 | 601.15 Million INR | 17.06% |
2018 | 513.55 Million INR | -4.79% |
2017 | 539.38 Million INR | -3.75% |
2016 | 560.41 Million INR | -3.43% |
2015 | 580.3 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2024 Q2 | 1.15 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 1.01 Billion INR | 0.0% |
2023 FY | 1.01 Billion INR | 14.34% |
2023 Q2 | 956.55 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 FY | 888.67 Million INR | 12.93% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 888.67 Million INR | 0.0% |
2022 Q2 | 849.34 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | 786.9 Million INR | 3.02% |
2021 Q4 | 786.9 Million INR | 0.0% |
2021 Q2 | 735.58 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2020 FY | 763.84 Million INR | 27.06% |
2020 Q2 | 672.72 Million INR | 0.0% |
2020 Q4 | 763.84 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2019 FY | 601.15 Million INR | 17.06% |
2019 Q1 | 587.17 Million INR | 14.33% |
2019 Q4 | 601.15 Million INR | 0.0% |
2019 Q2 | 587.17 Million INR | 0.0% |
2019 Q3 | 601.15 Million INR | 2.38% |
2018 FY | 513.55 Million INR | -4.79% |
2018 Q3 | 512.67 Million INR | -7.88% |
2018 Q4 | 513.55 Million INR | 0.17% |
2018 Q2 | 556.5 Million INR | 0.0% |
2018 Q1 | 556.5 Million INR | 0.0% |
2017 FY | 539.38 Million INR | -3.75% |
2016 FY | 560.41 Million INR | -3.43% |
2015 FY | 580.3 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aarti Drugs Limited | 24.32 Billion INR | 95.823% |
Albert David Limited | 4.97 Billion INR | 79.596% |
Alembic Limited | 23.28 Billion INR | 95.637% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -115.814% |
Hester Biosciences Limited | 6.62 Billion INR | 84.659% |
Hikal Limited | 24.87 Billion INR | 95.915% |
Ind-Swift Limited | 6.54 Billion INR | 84.474% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | 57.673% |
Unichem Laboratories Limited | 31.69 Billion INR | 96.794% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 98.424% |
Bafna Pharmaceuticals Limited | 1.47 Billion INR | 31.196% |
Bajaj HealthCare Limited | 7.65 Billion INR | 86.72% |
Brooks Laboratories Limited | 904.45 Million INR | -12.345% |
Eris Lifesciences Limited | 70.48 Billion INR | 98.558% |
Solara Active Pharma Sciences Limited | 23.46 Billion INR | 95.67% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | 53.191% |
Wanbury Limited | 3.43 Billion INR | 70.418% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 96.065% |
Alkem Laboratories Limited | 155.74 Billion INR | 99.348% |
FDC Limited | 24.68 Billion INR | 95.883% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 96.435% |
Gufic Biosciences Limited | 10.92 Billion INR | 90.7% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 91.279% |
Innova Captab Limited | 13.2 Billion INR | 92.307% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 95.473% |
Ipca Laboratories Limited | 111.01 Billion INR | 99.085% |
Jubilant Pharmova Limited | 115.48 Billion INR | 99.12% |
Lincoln Pharmaceuticals Limited | 7 Billion INR | 85.49% |
Lupin Limited | 239.97 Billion INR | 99.577% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 69.525% |
Medico Remedies Limited | 961.95 Million INR | -5.63% |
Morepen Laboratories Limited | 12.93 Billion INR | 92.143% |
Nectar Lifesciences Limited | 21.91 Billion INR | 95.362% |
Orchid Pharma Limited | 15.53 Billion INR | 93.461% |
Procter & Gamble Health Limited | 7.94 Billion INR | 87.208% |
RPG Life Sciences Limited | 5.12 Billion INR | 80.188% |
Sigachi Industries Limited | 6.94 Billion INR | 85.362% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.881% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 95.492% |
Themis Medicare Limited | 5.66 Billion INR | 82.061% |
Vaishali Pharma Limited | 799.55 Million INR | -27.084% |
Venus Remedies Limited | 6.26 Billion INR | 83.79% |
Windlas Biotech Limited | 6.26 Billion INR | 83.774% |
ZIM Laboratories Limited | 4.46 Billion INR | 77.259% |
Sakar Healthcare Limited | 3.88 Billion INR | 73.856% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.775% |
Divi's Laboratories Limited | 154.7 Billion INR | 99.343% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 90.574% |
Mankind Pharma Limited | 119.63 Billion INR | 99.151% |
Sequent Scientific Limited | 15.4 Billion INR | 93.404% |
Laurus Labs Limited | 83.87 Billion INR | 98.788% |
Neuland Laboratories Limited | 18.32 Billion INR | 94.455% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 97.456% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 99.292% |
Zydus Lifesciences Limited | 292.8 Billion INR | 99.653% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 72.303% |
Wockhardt Limited | 76.49 Billion INR | 98.672% |
Bal Pharma Limited | 3.2 Billion INR | 68.285% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.738% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 91.629% |
Caplin Point Laboratories Limited | 26.97 Billion INR | 96.233% |
Shilpa Medicare Limited | 30.93 Billion INR | 96.715% |
Valiant Laboratories Limited | 3.42 Billion INR | 70.349% |
Ajanta Pharma Limited | 46.38 Billion INR | 97.809% |
Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | 66.684% |
Granules India Limited | 55.2 Billion INR | 98.16% |
Medicamen Biotech Limited | 2.94 Billion INR | 65.5% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 74.89% |
Piramal Enterprises Limited | 826.05 Billion INR | 99.877% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 99.325% |
NATCO Pharma Limited | 69.06 Billion INR | 98.529% |
Suven Life Sciences Limited | 2.84 Billion INR | 64.335% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | 42.971% |
Strides Pharma Science Limited | 58.39 Billion INR | 98.26% |
Indoco Remedies Limited | 21.44 Billion INR | 95.262% |
Alpa Laboratories Limited | 1.82 Billion INR | 44.36% |
Lasa Supergenerics Limited | 1.5 Billion INR | 32.649% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 80.271% |